BDTX   $2.11  -1.86% Market Closed After Close 2.2 4.27%

Black Diamond Therapeutics, Inc.
Total Cash 122.97M
totalCashPerShare 2.176
EBITDA -86.87M
Total Debt 23.78M
quickRatio 6.669
currentRatio 6.874
Total Revenue
debtToEquity 21.421
Revenue/Share
ROA -0.4041
ROE -0.83375
grossProfits
freeCashflow -38.96M
operatingCashflow -68.24M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 69.76M
forwardPE -2.5503876
floatShares 44.48M
sharesOutstanding 56.50M
sharesShort 7.32M
sharesShortPriorMonth 5.86M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.95%
Short Ratio help_outline 3.06%
shortPercentOfFloat 0.22%
impliedSharesOutstanding
bookValue 2.26
Price To Book help_outline 1.46
earningsQuarterlyGrowth
netIncomeToCommon -80.55M
trailingEps -1.33%
forwardEps -1.29%
enterpriseToEbitda -0.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 4Q 2024
institutionsCount 125
lastUpdated Nov. 7, 2024, 3:10 a.m.